Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Actelion Ltd.
DescriptionSphingosine 1 phosphate receptor modulator
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationLupus
Indication DetailsTreat systemic lupus erythematosus (SLE)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today